With extensive background in venture capital, the fund manager has successfully led over 25 investments across technology and healthcare sectors. Active primarily in North America and Europe, their strategic operator-first approach has yielded notable exits, including a significant acquisition in the biotech space. The focus on early-stage investments reflects a commitment to nurturing innovative startups with transformative potential. Their data-driven methodology ensures rigorous analysis at every investment stage, enhancing portfolio performance and growth.